Fonte: Biochimica et Biophysica Acta. Unidades: FMRP, FORP
Assuntos: DOENÇAS IMUNOLÓGICAS, MUTAÇÃO GENÉTICA
ABNT
TAMIA-FERREIRA, Márcia Cristina et al. Systemic lupus erythematosus patients under immunosuppressive treatment express high levels of the immunoglobulin lambda variable IGLV8S1 gene with silent somatic mutations. Biochimica et Biophysica Acta, v. 1586, p. 108-112, 2002Tradução . . Acesso em: 09 nov. 2024.APA
Tamia-Ferreira, M. C., Trevisan, G. L., Carvalho, I. F. de, & Passos, G. A. S. (2002). Systemic lupus erythematosus patients under immunosuppressive treatment express high levels of the immunoglobulin lambda variable IGLV8S1 gene with silent somatic mutations. Biochimica et Biophysica Acta, 1586, 108-112.NLM
Tamia-Ferreira MC, Trevisan GL, Carvalho IF de, Passos GAS. Systemic lupus erythematosus patients under immunosuppressive treatment express high levels of the immunoglobulin lambda variable IGLV8S1 gene with silent somatic mutations. Biochimica et Biophysica Acta. 2002 ; 1586 108-112.[citado 2024 nov. 09 ]Vancouver
Tamia-Ferreira MC, Trevisan GL, Carvalho IF de, Passos GAS. Systemic lupus erythematosus patients under immunosuppressive treatment express high levels of the immunoglobulin lambda variable IGLV8S1 gene with silent somatic mutations. Biochimica et Biophysica Acta. 2002 ; 1586 108-112.[citado 2024 nov. 09 ]